Most Read News
- Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration
- Researchers target the cell's 'biological clock' in promising new therapy to kill cancer cells
- Novartis collaborates with Intellia Therapeutics and Caribou Biosciences
- 'Glowing' new nanotechnology guides cancer surgery, also kills remaining malignant cells
- Nature, nurture and time
- An avocado a day keeps the cardiologist away
- Acquisition provides Pfizer with a preclinical CMV vaccine candidate
Company Profiles and News
Abbott |
Amgen |
AstraZeneca |
Bayer |
Boehringer Ingelheim |
Bristol-Myers Squibb |
Daiichi Sankyo |
Eli Lilly and Company |
Genzyme |
GlaxoSmithKline |
Lundbeck |
Merck |
Merck KGaA |
Novartis |
Novo Nordisk |
Nycomed |
Pfizer |
Roche |
Sanofi |
Shire |
Takeda |
UCB | ...
Showcase your Company Profile / News
Showcase your Company Profile / News
Pharmaceutical Companies
Business & Industry News
- Major milestone for GSK/NIH candidate Ebola vaccine as first doses shipped to Liberia for use in phase III clinical trial
- Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need
- Novartis Pharmaceuticals announces a joint investment company with Qualcomm
- Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology
- MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
- Acquisition provides Pfizer with a preclinical CMV vaccine candidate
- Novartis collaborates with Intellia Therapeutics and Caribou Biosciences
Research & Development News
- Long-term use of hormonal contraceptives is associated with an increased risk of brain tumors
- Drinking moderate amounts of alcohol is linked to reduced risk of heart failure
- Vitamin D protects against colorectal cancer by boosting the immune system
- Experts recommend weight loss drugs, surgery as supplement to lifestyle interventions
- Scientists develop novel platform for treatment of breast, pancreatic cancer
- Researchers dispute warning that drugs for high cholesterol could impair memory, cognitive function
- World first at the Montreal Heart Institute - personalized therapy for cardiovascular disease
Regulatory Affairs News
- FDA approves anti-clotting drug Savaysa
- FDA warns consumers about fraudulent Ebola treatment products
- FDA issues guidance to support the responsible development of nanotechnology products
- FDA launches openFDA to provide easy access to valuable FDA public data
- FDA requires removal of certain restrictions on the diabetes drug Avandia
- EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications
- FDA approves new drug to treat HIV infection